Table of Contents
What changed
Revenue rose from NZ$0.4m to NZ$2.4m (+469.6%), dominated by a new Honey segment (51.8% of revenue, NZ$1.3m) that was absent in HY21 and consistent with the King Honey acquisition flagged in the FY21 anchor. Gross margin compressed sharply to 35.8% from 64.2%, a decline of roughly 2,833bps. EBITDA was a NZ$1.8m loss and PBT/NPAT widened to a NZ$2.8m loss, versus a NZ$1.3m loss a year earlier (-120.1%); with income tax nil in both periods, PBT and NPAT move in lockstep. Operating cash outflow widened to NZ$4.6m from NZ$1.6m (-181.5%). The balance sheet was transformed: total assets jumped to NZ$46.2m (from NZ$8.5m), equity to NZ$28.2m, gross borrowings to NZ$13.2m (bank loans NZ$8.1m plus a NZ$5.1m subordinated note), and net debt swung from a NZ$1.7m net-cash position to NZ$10.9m net debt. Inventories stepped up from NZ$0.8m to NZ$14.1m.
What matters
- Cash burn scaled faster than revenue. Operating outflow of NZ$4.6m against a NZ$1.8m EBITDA loss implies heavy working-capital absorption, and the NZ$2.3m cash balance now sits against NZ$13.2m of gross borrowings. The subordinated note and bank debt have replaced the prior equity-funded posture.
- Margin quality deteriorated with the mix shift. The honey business is the largest and least loss-making segment (implied EBITDA margin ~-23.7%), but its inclusion has halved gross margin. Sale of goods (-84.5%) and agency services (-80.8%) remain deeply unprofitable at the segment EBITDA line.
- Strategy now requires the scaled business to show operating leverage. Annualised HY22 revenue of NZ$4.8m is roughly 4.2x FY21's NZ$1.1m, but the fixed-cost and inventory base has expanded alongside it; the PBT loss is more than double the prior half on a revenue base nearly six times larger.
Expectations
No quantified forward-work backlog, earnings guidance, or stated targets were disclosed in the extracted materials, so this release cannot be judged against a specific numerical goal. Seasonality context is limited: in FY21 the second half represented ~63% of revenue and ~56% of NPAT loss, suggesting 2H skew, but that shape predates the honey acquisition and is of limited use for HY22's transformed business. What the release does support is a materially higher revenue run-rate; what it does not support is a visible path to breakeven, given the NZ$1.8m EBITDA loss against NZ$2.4m of revenue.
Quality of result
The result looks scale-driven rather than earnings-accretive. Revenue growth is real but is arriving with sharply lower gross margins and a deeper absolute loss. Cash conversion deteriorated materially: operating outflow widened by NZ$3.0m while the EBITDA loss widened by a smaller amount, pointing to working-capital absorption as the dominant cash driver. Inventory days ballooned to ~1,659 (from ~994) and inventories alone represent roughly NZ$13.3m of incremental balance-sheet build — appropriate for a honey business but a meaningful call on funding until it sells through. Capex was modest at NZ$0.2m (7.2% of revenue), so free cash flow pre-lease of approximately -NZ$4.8m is essentially an operating cash-burn and inventory-build story rather than investment spend. Leverage direction is weakening: net debt of NZ$10.9m now sits against negative EBITDA, so a net debt/EBITDA ratio is not meaningful.
Quality of result (additional colour on durability)
Segment disclosure is not fully comparable period-to-period (prior-period segment revenues exceed total reported revenue per the calculation pass), and EBITDA is presented as a non-GAAP measure at segment level without a detailed reconciliation to statutory profit in the excerpt. That limits confidence in like-for-like segment trends.
Unresolved
- How quickly does the NZ$14.1m inventory position convert to cash, and what is the sell-through assumption behind the honey build?
- What are the covenants, maturity, and cost of the NZ$8.1m bank loan and NZ$5.1m subordinated note, and is further funding required before the business approaches breakeven?
- Why do the prior-period segment revenues exceed reported total revenue, and what is the reconciled comparable for sale of goods and agency services?
- Is there customer, channel, or supplier concentration in the honey business that would affect the margin trajectory?
- Given the step-change in cost base, at what revenue level does management see group EBITDA breakeven?
This briefing cannot assess share-price valuation, liquidity runway in months, or covenant headroom, because NTA per share, cash-flow forecasts, and debt terms were not in the extracted materials.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $2.4m | $0.4m | +469.6% ↑ |
| EBITDA | −$1.8m | — | — |
| Net profit after tax | −$2.8m | −$1.3m | -120.1% ↓ |
| Net cash inflow from operating activities | −$4.6m | −$1.6m | -181.5% ↓ |
| Profit before tax | −$2.8m | −$1.3m | -120.1% ↓ |
| Cash and cash equivalents | $2.3m | $1.9m | +18.9% ↑ |
| Total assets | $46.2m | $8.5m | +445.0% ↑ |
Reference: annolyse.ai/briefings/mee-hy22
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Sale of goods | $1.0m | $0.3m | −$0.8m | -34.3pp |
| Agency services | $0.2m | $0.3m | −$0.2m | -54.3pp |
| Honey | $1.3m | — | −$0.3m | n/a |
Reference: annolyse.ai/briefings/mee-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| OCF / EBITDA (cash conversion) | 253.4% | — | deteriorated |
| FCF pre-lease | −$4.8m | −$1.5m | −$3.3m |
| FCF / NPAT | 172.9% | 122.1% | complementary conversion metric |
| Capex % revenue | 7.2% | 24.3% | — |
| Capex | −$0.2m | $0.1m | −$0.3m |
| Debtor days | 144.7 | 222.0 | -77.3 days |
| Inventory days | 1659.1 | 994.1 | +665.0 days |
| Operating working capital | $16.0m | $1.3m | +$14.7m absorbed |
| Trade debtors | $1.9m | $0.5m | +$1.4m |
| Net debt | $10.9m | −$1.7m | +$12.6m |
| Gross borrowings | $13.2m | $0.2m | +$12.9m |
| ROE (annualised) | -31.2% | -38.0% | Strengthening |
| HY21 share of FY21 revenue | 37.1% | — | Other half was 62.9% |
| HY21 share of FY21 NPAT | 44.1% | — | Other half was 55.9% |
| Profit from continuing operations | −$2.8m | −$1.3m | −$1.5m |
Reference: annolyse.ai/briefings/mee-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.